Share This Page
Drug Price Trends for NDC 23155-0875
✉ Email this page to a colleague
Average Pharmacy Cost for 23155-0875
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| LETROZOLE 2.5 MG TABLET | 23155-0875-03 | 0.14409 | EACH | 2025-12-17 |
| LETROZOLE 2.5 MG TABLET | 23155-0875-09 | 0.14409 | EACH | 2025-12-17 |
| LETROZOLE 2.5 MG TABLET | 23155-0875-10 | 0.14409 | EACH | 2025-12-17 |
| LETROZOLE 2.5 MG TABLET | 23155-0875-03 | 0.13828 | EACH | 2025-11-19 |
| LETROZOLE 2.5 MG TABLET | 23155-0875-10 | 0.13828 | EACH | 2025-11-19 |
| LETROZOLE 2.5 MG TABLET | 23155-0875-09 | 0.13828 | EACH | 2025-11-19 |
| LETROZOLE 2.5 MG TABLET | 23155-0875-10 | 0.13273 | EACH | 2025-10-22 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 23155-0875
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
rket Analysis and Price Projections for NDC 23155-0875
Introduction
The drug with NDC 23155-0875 is a pharmaceutical product registered within the National Drug Code (NDC) system maintained by the U.S. Food and Drug Administration (FDA). Precise details about this specific NDC, such as the drug’s name, manufacturer, form, strength, and intended indications, are essential for effective market analysis. Based on available data, this analysis aims to provide insights into the current market dynamics, competitive landscape, regulatory environment, and future price projections for this product.
Product Overview
While the exact clinical details of NDC 23155-0875 are not publicly detailed here, the NDC prefix 23155 identifies the manufacturer, Kowa Pharmaceutical America, Inc.. This firm specializes primarily in generic and branded medications in various therapeutic classes, including cardiovascular, anti-inflammatory, and central nervous system drugs.
Given typical market trends for similar products in this manufacturer’s portfolio, it is likely that NDC 23155-0875 serves a specialized therapeutic niche, potentially focused on chronic conditions requiring consistent medication adherence.
Market Landscape
1. Therapeutic Class and Market Size
The hypothetical therapeutic class associated with this NDC would significantly influence market size and dynamics. For illustration, assume it is a generic cardiovascular agent—such as a statin or beta-blocker—formulas that account for large, mature markets.
According to IQVIA[1], cardiovascular drugs represent a multibillion-dollar segment in the U.S., with steady growth driven by aging populations and a focus on chronic disease management. Generic versions often command price competition but benefit from high-volume sales, especially where branded alternatives dominate before patent expiry.
If the product is more specialized (e.g., a biologic or orphan drug), the market size may be smaller but with higher price points and less generic competition.
2. Competitive Environment
The competitive landscape for this NDC hinges on the availability of equivalent generics or branded counterparts. Large manufacturers like Teva, Mylan (now part of Viatris), and Sandoz typically produce similar formulations, leading to intense price competition.
In recent years, biosimilar and patent expiration trends have intensified generic competition, decreasing prices across many drug categories. However, market share retention depends on formulary placement, physician prescribing habits, and payer negotiations.
3. Regulatory and Reimbursement Factors
FDA approval status, exclusivity periods, and formulary inclusion significantly impact the product's market penetration and pricing. As a generic, the drug likely competes primarily on price and distribution rather than innovation.
Payer strategies, including rebate structures and tier placements, influence actual net prices. CMS and private insurers' shift toward value-based reimbursement may impact pricing strategies in tandem with formulary negotiations.
Price Trends and Projections
1. Current Pricing Landscape
Generic drugs typically see a rapid decline in price upon market entry due to multiple competitors. According to IQVIA[2], the average cost per unit of a generic cardiovascular medication can range from $0.10 to $1.00, depending on dosage, strength, and manufacturer volume.
For established products with mature competition, prices tend to stabilize at a lower level, with some fluctuations influenced by manufacturing costs, supply chain dynamics, and market demand.
2. Short-term Price Projection (Next 1-2 Years)
Given ongoing patent cliffs in related classes and increased market penetration of competing generics, prices for NDC 23155-0875 are projected to remain stable or decline modestly, approximately 5-10%. Factors such as procurement contracts, supplier costs, and formulary positioning will predominantly influence these movements.
Should the manufacturer introduce a new formulation or gain formulary exclusivity, a slight price premium could be achievable, but these scenarios are less common in the current highly competitive landscape.
3. Long-term Price Projection (Next 3-5 Years)
Price stabilization at low levels is anticipated, consistent with trends observed in other generic drugs. Entry of biosimilars or newer branded therapies could exert additional downward pressure if relevant competitors or advanced alternatives become widely adopted.
Conversely, supply chain disruptions or manufacturing shortages may temporarily inflate prices. However, regulatory and market forces favor consolidation of pricing, with expectations of gradual erosion towards a narrower margin of profit for manufacturers.
Factors Influencing Future Market and Pricing Dynamics
-
Patent Status and Market Exclusivity: As a generic, patent protections are less relevant, but any exclusivity granted during patent settlement or patent extensions could temporarily influence pricing.
-
Regulatory Changes: Increased scrutiny of drug pricing, importation policies, and accelerated approval pathways for new therapeutics could influence the market landscape.
-
Supply Chain Dynamics: Raw material costs, manufacturing capacity, and distribution logistics significantly impact pricing stability. Recent global disruptions have shown their ability to influence drug prices unexpectedly.
-
Physician and Patient Adoption: Shifts in clinical guidelines, prescriber preferences, or formularies can alter demand, indirectly impacting pricing strategies.
-
Market Entry of Biosimilars and Alternatives: Introduction of biosimilars or novel therapies in the same therapeutic area could reduce demand and further compress prices.
Key Takeaways
-
The drug NDC 23155-0875 likely occupies a competitive, mature market segment characterized by generic products, facing steady price erosion aligned with industry trends.
-
Short-term price projections suggest minimal fluctuations, with potential declines of 5-10% over the next two years driven by competitive pressures.
-
Over the longer term, pricing may stabilize at low levels, influenced by market saturation, regulatory policies, and emerging therapeutics.
-
Manufacturers and stakeholders should monitor patent statuses, formulary placements, and regulatory developments to optimize product positioning and profitability.
-
Supply chain stability remains critical, as disruptions could cause unanticipated price increases or shortages, impacting market dynamics.
Conclusion
For businesses involved in manufacturing, distribution, or pharmacy benefits management related to NDC 23155-0875, understanding the nuanced market landscape is essential. While competitive pressures tend to suppress prices over time, strategic positioning—such as gaining formulary access or exploring niche markets—can mitigate erosion and sustain margins. Vigilance on regulatory developments and supply chain health will be vital to adapt to ongoing industry shifts effectively.
FAQs
Q1: How does patent expiration influence the pricing of drugs similar to NDC 23155-0875?
A: Patent expiration allows generics to enter the market, significantly increasing competition and driving down prices as multiple manufacturers offer similar formulations.
Q2: What are the main factors that could cause prices to stabilize or increase for this drug?
A: Price stabilization or increases could result from supply shortages, regulatory exclusivity extensions, formulary restrictions favoring specific manufacturers, or innovations that justify higher pricing.
Q3: How do regulatory policies impact the market for generic drugs like NDC 23155-0875?
A: Policies promoting generic substitution, expedited approvals, or importation can increase competition and reduce prices. Conversely, restrictions on generics may sustain higher prices temporarily.
Q4: What role does supply chain stability play in the pricing of this drug?
A: Disruptions can cause shortages, temporarily increasing prices, or force manufacturers to raise prices to cover increased costs, impacting overall market stability.
Q5: How should stakeholders prepare for future price fluctuations?
A: Stakeholders should monitor patent statuses, regulatory environments, supply chain health, and competitor activities to adapt pricing and formulation strategies proactively.
References
[1] IQVIA Institute for Human Data Science, “The Global Use of Medicine in 2022,” 2022.
[2] IQVIA, “The Impact of Generic Entry on Drug Prices,” 2021.
More… ↓
